These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2457462)

  • 21. Monoclonal antibodies can precipitate low-density lipoprotein. II. Radioimmunoassays with single and combined monoclonal antibodies for determining apolipoprotein B in serum of patients with coronary artery disease.
    Marcovina S; Kottke BA; Mao SJ
    Clin Chem; 1985 Oct; 31(10):1659-63. PubMed ID: 3930092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of monoclonal antibodies against apolipoproteins A-I and A-II. Epitope expression in LpA-I and LpA-I:A-II particles.
    Ulloa N; Bustos P; Castro G; Fruchart J; Vera M; Fruchart JC; Calvo C
    Hybridoma; 1999 Dec; 18(6):513-20. PubMed ID: 10626680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The production and utility of monoclonal antibodies to rat apolipoprotein B lipoproteins.
    Sparks JD; Bolognino M; Trax PA; Sparks CE
    Atherosclerosis; 1986 Sep; 61(3):205-11. PubMed ID: 2429674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies distinguish between lipid-dependent and reversible conformational states of human apolipoprotein B.
    Milne RW; Blanchette L; Théolis R; Weech PK; Marcel YL
    Mol Immunol; 1987 May; 24(5):435-47. PubMed ID: 2443835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.
    Dullaart RP; Speelberg B; Schuurman HJ; Milne RW; Havekes LM; Marcel YL; Geuze HJ; Hulshof MM; Erkelens DW
    J Clin Invest; 1986 Nov; 78(5):1397-404. PubMed ID: 2429992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
    Milne RW; Weech PK; Blanchette L; Davignon J; Alaupovic P; Marcel YL
    J Clin Invest; 1984 Mar; 73(3):816-23. PubMed ID: 6368590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of unique antigenic determinants on human plasma low density lipoprotein and on delipidated apolipoprotein B.
    Watt TS; Watt RM
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):124-8. PubMed ID: 6185956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoreactivity of apo B towards monoclonal antibodies that inhibit the LDL-receptor interaction: effects of LDL oxidation.
    Negri S; Roma P; Fogliatto R; Uboldi P; Marcovina S; Catapano AL
    Atherosclerosis; 1993 Jun; 101(1):37-41. PubMed ID: 7692863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fenofibrate on apolipoprotein B containing lipoprotein particles.
    Fruchart JC; Bard JM; Fievet C; Kandoussi A; Slimane M; Douste-Blazy P
    Prog Clin Biol Res; 1988; 255():305-10. PubMed ID: 3277201
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of blood profile of atherogenic lipids using immunologic techniques].
    Fruchart JC; Bard JM; Clavey V; Fievet C
    Klin Wochenschr; 1990; 68 Suppl 22():43-5. PubMed ID: 2087078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of monoclonal antibodies to the assay of apolipoproteins].
    Marcel YL; Weech PK; Milne RW
    Ann Biol Clin (Paris); 1986; 44(5):536-44. PubMed ID: 2433973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of the immunoenzyme technic in double determination of antibodies for the study of hyperlipoproteinemia].
    Kandoussi A; Cachera C; Reade R; Tacquet A; Fruchart JC
    Ann Biol Clin (Paris); 1990; 48(6):365-8. PubMed ID: 2221495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies of predetermined specificity to apolipoprotein C-II elicited with a synthetic peptide. Characterization and use for immunoassays.
    Delpierre C; Fievet C; Equagoo V; Mezdour H; Cachera C; Gesquière JC; Tartar A; Fruchart JC
    J Immunol Methods; 1988 Apr; 109(1):61-8. PubMed ID: 2451696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of fenofibrate treatment on type III hyperlipoproteinemia.
    Fruchart JC; Davignon J; Bard JM; Grothe AM; Richard A; Fievet C
    Am J Med; 1987 Nov; 83(5B):71-4. PubMed ID: 3688011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies to human apolipoprotein A-I: characterization and application as structural probes for apolipoprotein A-I and high density lipoprotein.
    Petit E; Ayrault-Jarrier M; Pastier D; Robin H; Polonovski J; Aragon I; Hervaud E; Pau B
    Biochim Biophys Acta; 1987 Jun; 919(3):287-96. PubMed ID: 2439127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
    Hahn SE; Goldberg DM
    Biochem Pharmacol; 1992 Feb; 43(3):625-33. PubMed ID: 1311585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a).
    Marcovina SM; Albers JJ; Gabel B; Koschinsky ML; Gaur VP
    Clin Chem; 1995 Feb; 41(2):246-55. PubMed ID: 7533064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of monoclonal antibodies to apolipoprotein (a) and development of a chemiluminescent assay for phenotyping apolipoprotein (a) isomorphs.
    Théolis R; Breckenridge WC
    J Immunol Methods; 1994 Jun; 172(1):43-58. PubMed ID: 7515934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese women.
    Ferrer F; Nazih H; Zaïr Y; Krempf M; Bard JM
    Metabolism; 2003 Dec; 52(12):1537-41. PubMed ID: 14669151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.